Yale VAMOS Program Provides Holistic Vascular Care
The Vascular Medicine OutcomeS (VAMOS) program at Yale University, an integral program supported by the Yale New Haven Health’s Heart and Vascular Center and Center for Musculoskeletal Care, includes a global team of interventional cardiologists, vascular surgeons, podiatrists, radiologists, allied health professionals, and outcomes researchers committed to transforming how PAD is diagnosed and treated, and how patients access care.
Real-world outcomes study targets patients undergoing intravascular lithotripsy treatment at Yale
An observational study at the Heart and Vascular Center (HVC) at Yale New Haven Hospital (YNHH) Heart and Vascular Center could have major implications for patients with peripheral artery disease or PAD.
Randomized Clinical Trial Examines Facilitator-Led Interventions and Self-Administered Tools in Advance Care Planning Engagement
Patient engagement in advance care planning (ACP) is an important and yet challenging goal for clinicians. Several tradeoffs exist between facilitator-led ACP interventions and their required resources compared with self-administered tools.
Provision of Mental Health Services in the Veterans Health Administration: A Nationwide Comparison With Other Providers
On average, Veterans Health Administration (VHA) mental healthcare facilities offer significantly more treatment modalities, specialized services, and dedicated treatment programs than non-VHA facilities, according to a new study by Yale Psychiatry researchers published online in Psychiatric Services.
‘Prime and Spike’ Nasal Vaccine Strategy Helps Combat COVID
The new “prime” and “spike” approach may help prevent breakthrough infections of vaccinated individuals by bolstering immune response within the mucosal lining of the respiratory tract, which are the first cells attacked by COVID-19.Source: YaleNews
Glazer and Omer Are New Members of National Academy of Medicine
Two Yale faculty members, Peter M. Glazer, MD, PhD; and Saad B. Omer, MBBS, MPH, PHD; have been elected to the prestigious National Academy of Medicine, the academy announced today. Founded in 1970 as the Institute of Medicine the National Academy of Medicine (NAM) is one of three academies that make up the National Academies of Sciences, Engineering, and Medicine (the National Academies) in the United States.
Juan Vasquez, MD, Vidya Puthenpura, MD, MHS, FAAP, Awarded Grants to Further Pediatric Cancer Research
Two rising young stars of pediatric cancer research at Yale Cancer Center and Yale School of Medicine were awarded research grants from Hyundai Hope on Wheels program to further their work of improving outcomes and treatment for children diagnosed with cancer.
Building Momentum: WHRY's Undergraduate Fellows Advance Women's Health
Women’s Health Research at Yale mentors undergraduate students as well as graduate students and rising junior faculty members to ensure that the next generation of scientists and medical providers fully account for the health needs of women and sex-and-gender differences affecting health. Here are a few examples of what our former undergraduate fellows are up to now.
Sex Differences in Gastrointestinal Cancer
With this year's Wendy U. and Thomas C. Naratil Pioneer Award and co-funding from the Yale Cancer Center, Dr. Pamela Kunz is conducting one of the first studies to examine sex differences in treating neuroendocrine neoplasms (NENs), a rare form of cancer often found in the gastrointestinal tract.
Fighting Breast and Ovarian Cancer With a Lupus Antibody
After discovering a specific lupus antibody that can penetrate cancer cells and, with a grant from Women's Health Research at Yale, showing it makes cancer cells vulnerable to standard treatments, Dr. Peter Glazer and his colleagues are moving a treatment to clinical trials.
Ensuring Bone Health for Adolescents Identifying as Transgender
With a grant from Women's Health Research at Yale, Dr. Stuart Weinzimer, in collaboration with Drs. Thomas Carpenter and Christy Olezeski, is using sophisticated methods to obtain a picture of the dynamic process of bone development in adolescents undergoing gender-affirming hormone therapy.
Women: What's in a Name?
Today, as our scientific and cultural understanding expands, we have learned that sex and gender are not binary. And, in science, as our knowledge grows so must our efforts to welcome everyone in the identities they bring, and to enhance the precision of our language in adopting terms that value everyone. Even so, we must not forget our history and the descriptive terms that serve us well.
Yale Cancer Center Researchers Awarded Grants by Breast Cancer Research Foundation
The Breast Cancer Research Foundation (BCRF) Scientific Advisory Board and its Board of Directors recently announced its 2022 research grants, including six funded grants at Yale Cancer Center and Smilow Cancer Hospital awarded to Mehra Golshan, MD, MBA, Melinda Irwin, PhD, MPH, Ian Krop, MD, PhD, Lajos Pusztai, MD, DPhil, David Rimm, MD, PhD, and Eric Winer, MD to support their research.
Provision of 1-year mortality data for patients hospitalized with heart failure does not influence clinical decision-making – The REVEAL-HF trial
No significant differences in targeted interventions occurred between patients with heart failure managed by clinicians with additional prognostic information compared to those without.Source: 2minutemedicine